In in vitro killing assays, CD8+NK1.1+ NKT-like cells exerted cytotoxicity against tumor cells and MDSCs (myeloid derived suppressor cells) through a granzyme B-mediated granule exocytosis pathway. Here, CD8A is linked to neoplasm.